124 related articles for article (PubMed ID: 37878674)
1. DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity.
Wichroski M; Benci J; Liu SQ; Chupak L; Fang J; Cao C; Wang C; Onorato J; Qiu H; Shan Y; Banas D; Powles R; Locke G; Witt A; Stromko C; Qi H; Zheng X; Martin S; Ding M; Gentles R; Meanwell N; Velaparthi U; Olson R; Wee S; Tenney D; Parker CG; Cravatt BF; Lawrence M; Borzilleri R; Lees E
Sci Transl Med; 2023 Oct; 15(719):eadh1892. PubMed ID: 37878674
[TBL] [Abstract][Full Text] [Related]
2. Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
Arranz-Nicolás J; Martin-Salgado M; Adán-Barrientos I; Liébana R; Del Carmen Moreno-Ortíz M; Leitner J; Steinberger P; Ávila-Flores A; Merida I
Cancer Immunol Immunother; 2021 Nov; 70(11):3277-3289. PubMed ID: 33837851
[TBL] [Abstract][Full Text] [Related]
3. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling.
Joshi RP; Schmidt AM; Das J; Pytel D; Riese MJ; Lester M; Diehl JA; Behrens EM; Kambayashi T; Koretzky GA
Sci Signal; 2013 Nov; 6(303):ra102. PubMed ID: 24280043
[TBL] [Abstract][Full Text] [Related]
4. Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death of melanoma cells.
Takao S; Akiyama R; Sakane F
J Cell Biochem; 2021 May; 122(5):494-506. PubMed ID: 33399248
[TBL] [Abstract][Full Text] [Related]
5. DGKζ exerts greater control than DGKα over CD8
Gu J; Wang C; Cao C; Huang J; Holzhauer S; Desilva H; Wesley EM; Evans DB; Benci J; Wichroski M; Wee S; Riese MJ
Oncoimmunology; 2021; 10(1):1941566. PubMed ID: 34350062
[TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals.
Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A
Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701
[TBL] [Abstract][Full Text] [Related]
7. Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes.
Arranz-Nicolás J; Martin-Salgado M; Rodríguez-Rodríguez C; Liébana R; Moreno-Ortiz MC; Leitner J; Steinberger P; Ávila-Flores A; Merida I
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33246984
[TBL] [Abstract][Full Text] [Related]
8. Diacylglycerol Kinase ζ Limits Cytokine-dependent Expansion of CD8
Andrada E; Liébana R; Merida I
EBioMedicine; 2017 May; 19():39-48. PubMed ID: 28438506
[TBL] [Abstract][Full Text] [Related]
9. T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia.
Jing W; Gershan JA; Holzhauer S; Weber J; Palen K; McOlash L; Pulakanti K; Wesley E; Rao S; Johnson BD; Riese MJ
Cancer Res; 2017 Oct; 77(20):5676-5686. PubMed ID: 28916658
[TBL] [Abstract][Full Text] [Related]
10. Predominant contribution of DGKζ over DGKα in the control of PKC/PDK-1-regulated functions in T cells.
Ávila-Flores A; Arranz-Nicolás J; Andrada E; Soutar D; Mérida I
Immunol Cell Biol; 2017 Jul; 95(6):549-563. PubMed ID: 28163304
[TBL] [Abstract][Full Text] [Related]
11. Diacylglycerol kinases in cancer.
Mérida I; Torres-Ayuso P; Ávila-Flores A; Arranz-Nicolás J; Andrada E; Tello-Lafoz M; Liébana R; Arcos R
Adv Biol Regul; 2017 Jan; 63():22-31. PubMed ID: 27697466
[TBL] [Abstract][Full Text] [Related]
12. SAP-mediated inhibition of diacylglycerol kinase α regulates TCR-induced diacylglycerol signaling.
Baldanzi G; Pighini A; Bettio V; Rainero E; Traini S; Chianale F; Porporato PE; Filigheddu N; Mesturini R; Song S; Schweighoffer T; Patrussi L; Baldari CT; Zhong XP; van Blitterswijk WJ; Sinigaglia F; Nichols KE; Rubio I; Parolini O; Graziani A
J Immunol; 2011 Dec; 187(11):5941-51. PubMed ID: 22048771
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy for hepatocellular carcinoma with diacylglycerol kinase alpha inhibition and anti-programmed cell death-1 ligand blockade.
Okada N; Sugiyama K; Shichi S; Shirai Y; Goto K; Sakane F; Kitamura H; Taketomi A
Cancer Immunol Immunother; 2022 Apr; 71(4):889-903. PubMed ID: 34482409
[TBL] [Abstract][Full Text] [Related]
14. A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response.
Liu K; Kunii N; Sakuma M; Yamaki A; Mizuno S; Sato M; Sakai H; Kado S; Kumagai K; Kojima H; Okabe T; Nagano T; Shirai Y; Sakane F
J Lipid Res; 2016 Mar; 57(3):368-79. PubMed ID: 26768655
[TBL] [Abstract][Full Text] [Related]
15. Diacylglycerol kinase ζ controls diacylglycerol metabolism at the immunological synapse.
Gharbi SI; Rincón E; Avila-Flores A; Torres-Ayuso P; Almena M; Cobos MA; Albar JP; Mérida I
Mol Biol Cell; 2011 Nov; 22(22):4406-14. PubMed ID: 21937721
[TBL] [Abstract][Full Text] [Related]
16. Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity.
Chen SH; Dominik PK; Stanfield J; Ding S; Yang W; Kurd N; Llewellyn R; Heyen J; Wang C; Melton Z; Van Blarcom T; Lindquist KC; Chaparro-Riggers J; Salek-Ardakani S
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599020
[TBL] [Abstract][Full Text] [Related]
17. Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1.
Velnati S; Centonze S; Girivetto F; Baldanzi G
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072296
[TBL] [Abstract][Full Text] [Related]
18. DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity.
Kureshi R; Bello E; Kureshi CTS; Walsh MJ; Lippert V; Hoffman MT; Dougan M; Longmire T; Wichroski M; Dougan SK
Sci Adv; 2023 Nov; 9(47):eadk1853. PubMed ID: 38000024
[TBL] [Abstract][Full Text] [Related]
19. Identification of ritanserin analogs that display DGK isoform specificity.
Granade ME; Manigat LC; Lemke MC; Purow BW; Harris TE
Biochem Pharmacol; 2022 Mar; 197():114908. PubMed ID: 34999054
[TBL] [Abstract][Full Text] [Related]
20. Diacylglycerol kinase α promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src.
Torres-Ayuso P; Daza-Martín M; Martín-Pérez J; Ávila-Flores A; Mérida I
Oncotarget; 2014 Oct; 5(20):9710-26. PubMed ID: 25339152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
